Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect

Development of non-nucleoside reverse transcriptase inhibitors

Nucleotide and nucleoside-based drugs: past, present, and future

Current scenario on non-nucleoside reverse transcriptase

A review on synthesis of antiviral drugs, in silico studies and

Pharmaceuticals, Free Full-Text

Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief

Design of the naphthyl-diarylpyrimidines as potent non-nucleoside

Nutrients, Free Full-Text

Conformational restriction design of thiophene-biphenyl-DAPY HIV-1

The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside

Approved HIV reverse transcriptase inhibitors in the past decade